Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders
NCT07268729 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-04-29
Summary
This study aims to investigate the etiology of anxiety, depression, and panic disorders, providing new evidence and insights into the root causes and effective treatments, potentially offering a novel approach to achieving complete recovery.
Conditions
- Anxiety
- Panic Disorder
- Mood Disorders
- Depression
Interventions
- DIAGNOSTIC_TEST
-
H pylori stool test
Participants will provide a stool sample for noninvasive testing to detect the presence of Helicobacter pylori bacteria. The test will be performed using a validated laboratory assay that identifies H. pylori antigens in stool. Results will be used to assess potential associations between H. pylori infection, gut microbiome composition, and symptoms of anxiety or depression. The test is diagnostic only and does not involve administration of any drug or treatment.
- DIAGNOSTIC_TEST
-
Bacterial stool analysis
Participants will provide stool samples for microbiome sequencing using a validated laboratory assay. The analysis will characterize bacterial taxa within the gut microbiome and identify potential pathogenic species. Sequencing results will be correlated with psychological assessments and clinical measures to investigate relationships between gut microbial composition and symptoms of anxiety, depression, and panic disorder.
Sponsors & Collaborators
-
MedBliss Research Network
collaborator UNKNOWN -
University of Toronto
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-12-10
- Primary Completion
- 2026-01-25
- Completion
- 2026-02-10
Countries
- Canada
Study Locations
More Related Trials
-
Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia
NCT07187492 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Rifaximin on Gut Microbiota and Emotion
NCT05587036 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT05509725 ·Status: RECRUITING ·Phase: PHASE4
-
Mapping the Impact of Gut Microbiota on Brain and Behavior Through the Lens of GABA
NCT05698862 ·Status: RECRUITING ·Phase: NA
-
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study
NCT01829932 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiota in IBD With Comorbid Depressive Disorder
NCT07252427 ·Status: RECRUITING
-
Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT06960369 ·Status: RECRUITING ·Phase: PHASE1
-
Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario
NCT00235326 ·Status: COMPLETED
-
Neurocognitive Effects of FMT in MDD Patients With and Without IBS
NCT05174273 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder
NCT01337609 ·Status: TERMINATED ·Phase: PHASE4
-
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression
NCT04211467 ·Status: WITHDRAWN
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating
NCT02299973 ·Status: COMPLETED ·Phase: NA
-
Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase
NCT02566629 ·Status: UNKNOWN
-
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
NCT02108119 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)
NCT00194922 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome
NCT05064930 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiota in Chronic GI Diseases
NCT06532110 ·Status: RECRUITING
-
Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia
NCT07182890 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy of Probiotic Bacteria in Subjects With IBS or Functional Diarrhea/ Bloating
NCT00618904 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Multispecies Probiotic on Hypersensitivity in Irritable Bowel Syndrome (IBS) Patients
NCT00702026 ·Status: COMPLETED ·Phase: NA
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
Characterizing Protein Biomarkers of Post-infection Irritable Bowel Syndrome
NCT06032117 ·Status: COMPLETED
-
Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome
NCT02249169 ·Status: COMPLETED
-
Gut Microbiota in Mood Disorders in Lebanese Population
NCT05646784 ·Status: COMPLETED ·Phase: NA